High mdrl- and mrp-, but low topoisomerase IIα-gene expression in B-cell chronic lymphocytic leukaemias
- 28 October 1994
- journal article
- Published by Elsevier BV in Cancer Letters
- Vol. 86 (1), 135-142
- https://doi.org/10.1016/0304-3835(94)90190-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase π gene expression in primary and relapsed state adult and childhood leukaemiasBritish Journal of Cancer, 1992
- Biochemical Basis for Multidrug Resistance in CancerPublished by Elsevier BV ,1991
- Mdr1P-glycoprotein gene segments analyzed from various human leukemic cell lines exhibiting different multidrug resistance profilesBiochemical and Biophysical Research Communications, 1990
- Decreased nuclear matrix DNA topoisomerase II in human leukemia cells resistant to VM-26 and m-AMSABiochemistry, 1990
- Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase IIBiochemistry, 1989
- THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCEAnnual Review of Biochemistry, 1989
- ATP‐binding properties of P glycoprotein from multidrug‐resistant KB cellsThe FASEB Journal, 1987
- Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cellsCell, 1986
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979